Acid inactivation of prions: efficient at elevated temperature or high acid concentration.
暂无分享,去创建一个
D. Riesner | M. Beekes | M. Groschup | R. Lucassen | T. Appel | M. Joncic
[1] James E. Cleaver,et al. Search for a Prion-Specific Nucleic Acid , 2005, Journal of Virology.
[2] F. Cohen,et al. Synthetic Mammalian Prions , 2004, Science.
[3] B. Chesebro,et al. A View from the Top--Prion Diseases from 10,000 Feet , 2003, Science.
[4] A. Aguzzi,et al. Prion diseases: Cannibals and garbage piles , 2003, Nature.
[5] S. Prusiner,et al. Perspectives on prion biology, prion disease pathogenesis, and pharmacologic approaches to treatment. , 2003, Clinics in laboratory medicine.
[6] I. Mcconnell,et al. Thermostability of mouse-passaged BSE and scrapie is independent of host PrP genotype: implications for the nature of the causal agents. , 2002, The Journal of general virology.
[7] R. Somerville,et al. Characterization of Thermodynamic Diversity between Transmissible Spongiform Encephalopathy Agent Strains and Its Theoretical Implications* , 2002, The Journal of Biological Chemistry.
[8] David A Agard,et al. Structural studies of the scrapie prion protein by electron crystallography , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[9] D. Taylor,et al. Gastric Acidity Protects Mice Against Prion Infection? , 2002, Scandinavian journal of gastroenterology.
[10] S. Prusiner,et al. Shattuck lecture--neurodegenerative diseases and prions. , 2001, The New England journal of medicine.
[11] D. Riesner,et al. Heat stability of prion rods and recombinant prion protein in water, lipid and lipid-water mixtures. , 2001, The Journal of general virology.
[12] S. Prusiner,et al. Structural Intermediates in the Putative Pathway from the Cellular Prion Protein to the Pathogenic Form , 2001, Biological chemistry.
[13] F. Cohen,et al. Scrapie infectivity is independent of amyloid staining properties of the N-terminally truncated prion protein. , 2000, Journal of structural biology.
[14] D. Strack. Microcharacterization of Proteins (2nd edn): edited by R. Kellner, F. Lottspeich, H.E. Meyer, Wiley-VCH, Weinheim, XXI+325 pp. ISBN: 3-527-30084-8, DM 158.00. , 1999 .
[15] J. Darbord. Inactivation of prions in daily medical practice. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[16] D. Riesner,et al. Prion Rods Contain an Inert Polysaccharide Scaffold , 1999, Biological chemistry.
[17] Stanley B. Prusiner,et al. Nobel Lecture: Prions , 1998 .
[18] D. Kirsch,et al. Prion Rods Contain Small Amounts of Two Host Sphingolipids as Revealed by Thin-Layer Chromatography and Mass Spectrometry , 1998, Biological chemistry.
[19] M. Beekes,et al. Highly infectious purified preparations of disease-specific amyloid of transmissible spongiform encephalopathies are not devoid of nucleic acids of viral size. , 1997, Intervirology.
[20] M. Beekes,et al. Sequential appearance and accumulation of pathognomonic markers in the central nervous system of hamsters orally infected with scrapie. , 1996, The Journal of general virology.
[21] F. Cohen,et al. High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. , 1996, Biochemistry.
[22] S. Prusiner,et al. Disruption of prion rods generates 10-nm spherical particles having high alpha-helical content and lacking scrapie infectivity , 1996, Journal of virology.
[23] W. Schlote,et al. Tissue Handling in Suspected Creutzfeldt‐Jakob Disease (CJD) and Other Human Spongiform Encephalopathies (Prion Diseases) , 1995, Brain pathology.
[24] F. Lottspeich,et al. Microcharacterization of Proteins , 1994 .
[25] R. Race,et al. Comparative analysis of scrapie agent inactivation methods. , 1993, Journal of virological methods.
[26] C. Weissmann,et al. A 'unified theory' of prion propagation , 1991, Nature.
[27] S. Prusiner,et al. Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis , 1991, Journal of virology.
[28] P. Liberski,et al. Resistance of scrapie infectivity to steam autoclaving after formaldehyde fixation and limited survival after ashing at 360 degrees C: practical and theoretical implications. , 1990, The Journal of infectious diseases.
[29] H. Wiśniewski,et al. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins , 1987, Journal of virology.
[30] T. Sklaviadis,et al. Evidence suggesting that PrP is not the infectious agent in Creutzfeldt‐Jakob disease. , 1987, The EMBO journal.
[31] P. Brown,et al. Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue. , 1986, The Journal of infectious diseases.
[32] S. Prusiner,et al. Scrapie prions aggregate to form amyloid-like birefringent rods , 1983, Cell.
[33] S. Prusiner,et al. A protease-resistant protein is a structural component of the Scrapie prion , 1983, Cell.
[34] D. Taylor,et al. Disinfection studies with two strains of mouse-passaged scrapie agent Guidelines for Creutzfeldt-Jakob and related agents , 1983, Journal of the Neurological Sciences.
[35] S. Prusiner,et al. Further purification and characterization of scrapie prions. , 1982, Biochemistry.
[36] S. Prusiner,et al. Viroids and prions. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[37] S. Prusiner. Novel proteinaceous infectious particles cause scrapie. , 1982, Science.
[38] S. Prusiner,et al. Measurement of the scrapie agent using an incubation time interval assay , 1982, Annals of neurology.
[39] S. Prusiner,et al. Thiocyanate and hydroxyl ions inactivate the scrapie agent. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[40] J. Morris,et al. Scrapie in Mice , 1968, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[41] A. Dawson,et al. SCRAPIE IN MICE. THE STABILITY OF THE AGENT TO VARIOUS SUSPENDING MEDIA, PH AND SOLVENT EXTRACTION. , 1965, Research in veterinary science.
[42] D. Taylor,et al. Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie , 2005, Archives of Virology.
[43] D Riesner,et al. The prion theory: background and basic information. , 2001, Contributions to microbiology.
[44] J. Collinge. Prion diseases of humans and animals: their causes and molecular basis. , 2001, Annual review of neuroscience.
[45] H. Kretzschmar,et al. Prionen und Prionkrankheiten , 2001 .
[46] D. Taylor. Inactivation of transmissible degenerative encephalopathy agents: A review. , 2000, Veterinary journal.
[47] L. Manuelidis. Decontamination of Creutzfeldt-Jakob disease and other transmissible agents. , 1997, Journal of neurovirology.
[48] B. Chesebro. Transmissible spongiform encephalopathies: scrapie, BSE and related human disorders. , 1991, Current topics in microbiology and immunology.
[49] P. Brown,et al. The human spongiform encephalopathies: kuru, Creutzfeldt-Jakob disease, and the Gerstmann-Sträussler-Scheinker syndrome. , 1991, Current topics in microbiology and immunology.
[50] S. Prusiner,et al. IMMUNOAFFINITY PURIFICATION AND NEUTRALIZATION OF SCRAPIE PRIONS , 1988 .